000 | 01905 a2200553 4500 | ||
---|---|---|---|
005 | 20250515014141.0 | ||
264 | 0 | _c20060814 | |
008 | 200608s 0 0 eng d | ||
022 | _a1552-4949 | ||
024 | 7 |
_a10.1002/cyto.b.20086 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJankovic, B | |
245 | 0 | 0 |
_aComparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. _h[electronic resource] |
260 |
_bCytometry. Part B, Clinical cytometry _cMar 2006 |
||
300 |
_a45-55 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntigens, Neoplasm _xmetabolism |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 | _aCarbonic Anhydrase IX |
650 | 0 | 4 |
_aCarbonic Anhydrases _xmetabolism |
650 | 0 | 4 |
_aCell Hypoxia _xphysiology |
650 | 0 | 4 |
_aCervix Uteri _xmetabolism |
650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
650 | 0 | 4 | _aElectrodes |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xmetabolism |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNitroimidazoles _xmetabolism |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aS Phase |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xmetabolism |
700 | 1 | _aAquino-Parsons, C | |
700 | 1 | _aRaleigh, J A | |
700 | 1 | _aStanbridge, E J | |
700 | 1 | _aDurand, R E | |
700 | 1 | _aBanath, J P | |
700 | 1 | _aMacPhail, S H | |
700 | 1 | _aOlive, P L | |
773 | 0 |
_tCytometry. Part B, Clinical cytometry _gvol. 70 _gno. 2 _gp. 45-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cyto.b.20086 _zAvailable from publisher's website |
999 |
_c16070173 _d16070173 |